| [1] Stoltz M, Arumugham T, Lippert C, et al. Effect of food on the bioavailability of fexofenadine hydrochloride (MDL16455A) [J]. Biopharm Drug Dispos, 1997, 18 (7) : 645-648.
[2] Hofmann U, Seiler M, Drescher S, et al. Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry [J]. J Chromatogr B, 2002, 766 : 227-233.
[3] Russell T, Stoltz M, Weir S. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers [J]. Clin Pharmacol Ther, 1998, 64 (6) : 612-621.
[4] Bernstein DI, Schoenwetter WF, Nathan RA, et al. Efficacy and safety of fexofendine hydrochloride for treatment of seasonal allergic rhinitis [J]. Ann Allerg Asthma Im, 1997, 79 (44) : 3-8.
[5] Tinkelman D, Falliers C, Bronsky E, et al. Efficacy and safety of fexofenadine HCL in fall seasonal allergic rhinitis [Abstract]. J Allergy Clin Immunol, 1996, 97 (1 pt 3) : 435.
[6] Coutant J E, Westmark PA, Nardella PA, et al. Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and performance liquid chromatography with fluorescence detection [J]. J Chromatogr, 1991, 570 : 139-148.
[7] Surapaneni S, Khalil SKW. A sensitive HPLC method for the determination of terfenadine and its metabolite in human plasma [J]. J Liq Chromatogr, 1994, 17 : 2419-2428.
[8] Radhakrishna T, Om Reddy G. Simultaneous determination of fexofenadine and its related compounds hy HPLC [J]. J Pharm Biomed Anal, 2002, 29 : 681-690.
[9] Gazy A, Mahgoub H, El-Yazbi FA, et al. Determination of some histamine H1-receptor antagonists in dosage forms [J]. J Pharm Biomed Anal, 2002, 30 : 859-867. |
>
>